An iron oxide nanocarrier for dsRNA to target lymph nodes and strongly activate cells of the immune system.

Macarena Cobaleda-Siles, Malou Henriksen-Lacey, Ane Ruiz de Angulo, Anja Bernecker, Vanessa Gómez Vallejo, Boguslaw Szczupak, Jordi Llop, Géraldine Pastor, Sandra Plaza-Garcia, Maite Jauregui-Osoro, Levente K Meszaros, Juan C Mareque-Rivas

Index: Small 10(24) , 5054-67, (2014)

Full Text: HTML

Abstract

The success of nanoparticle-based therapies will depend in part on accurate delivery to target receptors and organs. There is, therefore, considerable potential in nanoparticles which achieve delivery of the right drug(s) using the right route of administration to the right location at the right time, monitoring the process by non-invasive molecular imaging. A challenge is harnessing immunotherapy via activation of Toll-like receptors (TLRs) for the development of vaccines against major infectious diseases and cancer. In immunotherapy, delivery of the vaccine components to lymph nodes (LNs) is essential for effective stimulation of the immune response. Although some promising advances have been made, delivering therapeutics to LNs remains challenging. It is here shown that iron-oxide nanoparticles can be engineered to combine in a single and small (<50 nm) nanocarrier complementary multimodal imaging features with the immunostimulatory activity of polyinosinic-polycytidylic acid (poly (I:C)). Whilst the fluorescence properties of the nanocarrier show effective delivery to endosomes and TLR3 in antigen presenting cells, MRI/SPECT imaging reveals effective delivery to LNs. Importantly, in vitro and in vivo studies show that, using this nanocarrier, the immunostimulatory activity of poly (I:C) is greatly enhanced. These nanocarriers have considerable potential for cancer diagnosis and the development of new targeted and programmable immunotherapies. © 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.